| Patent | Date |
|---|
Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
Grant 11,440,898 - Garcia Collazo , et al. September 13, 2 | 2022-09-13 |
Method Of Administering A Therapeutically Effective Amount Of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazo- Lidine-2,4-dione
App 20210308113 - Martinell Pedemonte; Marc ; et al. | 2021-10-07 |
Use Of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-- Dione And Its Salts
App 20210228558 - MARTINELL PEDEMONTE; Marc ; et al. | 2021-07-29 |
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazol- Idine-2,4-dione And Its Salts For Use In The Treatment Of Mitochondrial Diseases
App 20210228559 - MARTINELL PEDEMONTE; Marc ; et al. | 2021-07-29 |
5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazol- idine-2,4-dione for Treating Nonalcoholic Fatty Live
App 20200093812 - PIZCUETA LALANZA; Maria Pilar ; et al. | 2020-03-26 |
Isoquinoline Compounds, Methods For Their Preparation, And Therapeutic Uses Thereof In Conditions Associated With The Alteration
App 20200071294 - GARC A COLLAZO; Ana Maria ; et al. | 2020-03-05 |
2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
App 20190255032 - GARC A COLLAZO; Ana Maria ; et al. | 2019-08-22 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 10,329,256 - Ortega Munoz , et al. | 2019-06-25 |
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
Grant 10,233,178 - Ortega Munoz , et al. | 2019-03-19 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 10,214,477 - Ortega Munoz , et al. Feb | 2019-02-26 |
2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
Grant 10,179,126 - Garcia Collazo , et al. Ja | 2019-01-15 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20180354902 - Ortega Munoz; Alberto ; et al. | 2018-12-13 |
2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
App 20180133202 - GARC A COLLAZO; Ana Maria ; et al. | 2018-05-17 |
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use
App 20180127406 - ORTEGA MUNOZ; Alberto ; et al. | 2018-05-10 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 9,944,601 - Ortega Munoz , et al. April 17, 2 | 2018-04-17 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20180079709 - ORTEGA MUNOZ; Alberto ; et al. | 2018-03-22 |
Lysine demethylase inhibitors for myeloproliferative disorders
Grant 9,908,859 - Baker , et al. March 6, 2 | 2018-03-06 |
2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
Grant 9,782,395 - Garcia Collazo , et al. October 10, 2 | 2017-10-10 |
Lysine Demethylase Inhibitors For Myeloproliferative Or Lymphoproliferative Diseases Or Disorders
App 20170209432 - FYFE; Matthew Colin Thor ; et al. | 2017-07-27 |
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
Grant 9,708,309 - Ortega Munoz , et al. July 18, 2 | 2017-07-18 |
Cyclopropylamine derivatives useful as LSD1 inhibitors
Grant 9,676,701 - Fyfe , et al. June 13, 2 | 2017-06-13 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 9,670,136 - Ortega Munoz , et al. June 6, 2 | 2017-06-06 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20170008844 - ORTEGA MUNOZ; Alberto ; et al. | 2017-01-12 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20160368857 - ORTEGA MUNOZ; Alberto ; et al. | 2016-12-22 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 9,487,512 - Ortega Munoz , et al. November 8, 2 | 2016-11-08 |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
Grant 9,469,597 - Ortega Munoz , et al. October 18, 2 | 2016-10-18 |
2,4-thiazolidinedione Derivatives In The Treatment Of Central Nervous System Disorders
App 20160235729 - Garcia Collazo; Ana Maria ; et al. | 2016-08-18 |
Di(hetero)arylamides And Sulfonamides, Methods For Their Preparation And Therapeutic Uses Thereof
App 20160168132 - BARRIL ALONSO; Xavier ; et al. | 2016-06-16 |
Cyclopropylamine Derivatives Useful As Lsd1 Inhibitors
App 20160052865 - FYFE; Matthew Colin Thor ; et al. | 2016-02-25 |
Cyclopropylamine Inhibitors Of Oxidases
App 20160000768 - Castro-Palomino Laria; Julio ; et al. | 2016-01-07 |
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use
App 20150376177 - ORTEGA MUNOZ; Alberto ; et al. | 2015-12-31 |
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
Grant 9,181,198 - Ortega Munoz , et al. November 10, 2 | 2015-11-10 |
Lysine Demethylase Inhibitors For Myeloproliferative Disorders
App 20150232436 - Baker; Jonathan Alleman ; et al. | 2015-08-20 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20150119396 - Ortega Munoz; Alberto ; et al. | 2015-04-30 |
Cyclopropylamine derivatives useful as LSD1 inhibitors
Grant 9,006,449 - Fyfe , et al. April 14, 2 | 2015-04-14 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20150025054 - Ortega Munoz; Alberto ; et al. | 2015-01-22 |
Lysine Demethylase Inhibitors For Inflammatory Diseases Or Conditions
App 20140329833 - Maes; Tamara ; et al. | 2014-11-06 |
Lysine Demethylase Inhibitors For Thrombosis And Cardiovascular Diseases
App 20140296255 - Maes; Tamara ; et al. | 2014-10-02 |
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors
App 20140256729 - Ortega Munoz; Alberto ; et al. | 2014-09-11 |
Lysine Demethylase Inhibitors For Myeloproliferative Or Lymphoproliferative Diseases Or Disorders
App 20140163041 - Fyfe; Matthew Colin Thor ; et al. | 2014-06-12 |
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use
App 20130231342 - Munoz; Alberto Ortega ; et al. | 2013-09-05 |
Carboxylic Derivatives For Use In The Treatment Of Cancer
App 20110105544 - Aymami Bofarull; Juan ; et al. | 2011-05-05 |
| 